$DFTX 4 SEC Filings

Filed On	Filing
29 Sep 2026	Form 4: Karlin Daniel, Director Sold 10,853 shares ($397K)
29 Sep 2026	Form 4: Barrow Robert, Director Sold 31,550 shares ($1.15M)
29 Sep 2026	Form 4: Wiley Matthew T., Chief Commercial Officer Sold 3,097 shares ($113K)
29 Sep 2026	Form 4: Sullivan Mark, Chief Legal Officer Sold 14,051 shares ($514K)
29 Sep 2026	Form 4: Roberts Brandi, Chief Financial Officer Sold 3,377 shares ($123K)
18 Sep 2026	Form 4: Krebs Andreas, Director Received 1,629 shares by exercise or conversion ($57.9K)
18 Sep 2026	Form 4: Vallone Carol A, Director Received 1,086 shares by exercise or conversion ($38.6K)
14 Sep 2026	Form 4: Karlin Daniel, Chief Medical Officer Received 200,000 shares as a grant or award
14 Sep 2026	Form 4: Wiley Matthew T., Chief Commercial Officer Received 125,000 shares as a grant or award
14 Sep 2026	Form 4: Sullivan Mark, Chief Legal Officer Received 125,000 shares as a grant or award
14 Sep 2026	Form 4: Roberts Brandi, Chief Financial Officer Received 125,000 shares as a grant or award
14 Sep 2026	Form 4: Barrow Robert, Director Received 750,000 shares as a grant or award
04 Sep 2026	Form 4: Barrow Robert, Director Received 40,000 shares as a grant or award · Sold 19,023 shares ($722K)
12 Aug 2026	Form 4: Barrow Robert, Director Received 375,000 shares as a grant or award
12 Aug 2026	Form 4: Karlin Daniel, Chief Medical Officer Received 100,000 shares as a grant or award
12 Aug 2026	Form 4: Sullivan Mark, Chief Legal Officer Received 62,500 shares as a grant or award
12 Aug 2026	Form 4: Wiley Matthew T., Chief Commercial Officer Received 62,500 shares as a grant or award
12 Aug 2026	Form 4: Roberts Brandi, Chief Financial Officer Received 62,500 shares as a grant or award
26 Jun 2026	Form 4: Sullivan Mark, Chief Legal Officer Sold 13,008 shares ($586K)
26 Jun 2026	Form 4: Roberts Brandi, Chief Financial Officer Sold 3,013 shares ($136K)

Comments